Search
for
Sort by
Research 211–240 of 1000+
- Rash from EGFR inhibitors: Opportunities and challenges for palliation
- Chinese Herbal Medicine for Reducing Chemotherapy-Associated Side-Effects in Breast Cancer Patients: A Systematic Review and Meta-Analysis
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Management of patients and side effects during cyclosporine therapy for cutaneous disorders
- The efficacy and particular side effects of therapy peginterferon alpha-2a acute hepatitis C hemodialysed patients
- The Chinese herb Xiaoaiping protects against breast cancer chemotherapy-induced alopecia and other side effects: a randomized controlled trial
- Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings
- Perspectives in Head and Neck Medical Oncology
- Preclinical Challenges in Proton Minibeam Radiotherapy: Physics and Biomedical Aspects
- “PRIDE” Complex
- New Selenoderivatives as Antitumoral Agents
- Current Management and Treatment Options for Breast Pain
- mRNA-Based Delivery of Dsup Protein for Acute Radioprotection in Human Cells Without Genomic Alteration
- DRUG NEWS
- Erlotinib induced acneiform eruption: A case report
- Epidermal growth factor receptor inhibitor Geftinib-induced erosive pustular dermatosis of the scalp – A report with a brief review of the literature
- Ανάπτυξη καινοτόμων πεπτιδικών φορέων με ιδιότητες αυτοσυναρμογής για τοπική χορήγηση φαρμάκων
- MARIO LACOUTURE: How Do I Treat a Patient with Dermatologic Toxicities to EGFR Inhibitors?
- Noyes-Whitney Dissolution Model-Based pH-Sensitive Slow Release of Paclitaxel (Taxol) from Human Hair-Derived Keratin Microparticle Carriers
- Sex Hormones and Related Compounds, Including Hormonal Contraceptives
- 14 Dermatological drugs, topical agents, and cosmetics
- Pattern of short-term adverse effects in patients undergoing low-dose radioactive iodine therapy
- The safety of 52 weeks of oral DHEA therapy for postmenopausal women
- Presentation, impact and prevention of chemotherapy-induced hair loss: scalp cooling potentials and limitations
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- High Response Rate to Bexxar in Advanced Stage Prior Treatment-Resistant Follicular Lymphoma
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- Hair shaft abnormalities after chemotherapy and tamoxifen therapy in patients with breast cancer evaluated by optical coherence tomography